Madrigal Pharmaceuticals Inc (MDGL)
308.71
+15.30
(+5.21%)
USD |
NASDAQ |
Dec 20, 16:00
307.91
-0.80
(-0.26%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Quarterly): 777.16M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 638.84M |
| 89bio Inc | 378.10M |
| ADMA Biologics Inc | 231.89M |
| Matinas BioPharma Holdings Inc | 15.78M |
| Viking Therapeutics Inc | 911.45M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.073B |
| Total Liabilities (Quarterly) | 296.11M |
| Debt to Equity Ratio | 0.1507 |
| Current Ratio | 5.981 |
| Net Debt Paydown Yield | -0.08% |